Clinical Frailty Assessment and Postoperative Adverse Outcomes and Quality of Life in Elderly Patients
NCT ID: NCT05387850
Last Updated: 2024-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12000 participants
OBSERVATIONAL
2020-09-20
2022-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Frailty Trajectories and One-Year Mortality in Older Surgical Patients
NCT07322809
Preoperative Frailty and Postoperative Prognosis in the Elderly After Major Surgeries
NCT04655651
The Effect of Frailty to Perioperative Complications in the Elderly
NCT04120012
Frailty Index as An Indicator Associated With Postoperative Adverse Outcomes In The Older Population
NCT05742737
Frailty Assessment of Patients With Gastrointestinal Surgery
NCT03930082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Elderly patients continue to pose a major threat to the world's rapidly ageing population due to high rates of surgery and postoperative complications in elderly patients. Therefore, optimizing perioperative management strategies for elderly patients remains one of the biggest challenges facing clinicians.
Frailty is a multidimensional clinical syndrome characterized by vulnerability to dependence and increased mortality when exposed to stressors. It is often clinically described as a lack of physiological reserve, manifested as a loss of physical ability, metabolic function, and cognitive abilities. A systematic review of studies of patients in general surgery reported that the prevalence of prefrailty was estimated to be between 11.3% and 45.8%, while the prevalence of frailty was estimated to be between 10.4% and 37.0%.
Although clinicians or relatives may be aware of frailty, there is currently no standardized clinical gold-standard assessment tool to widely use and quantify frailty.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elderly patients over the age of 65
Elderly patients over the age of 65 undergoing elective non-cardiac surgery
no intervention
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-selective cardiac surgery
Exclusion Criteria
* ASA degree V
* Delirium before surgery
* Patient refused to enroll
65 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tiantan Hospital
OTHER
Peking University First Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Xiangya Hospital of Central South University
OTHER
Beijing Anzhen Hospital
OTHER
Central South University
OTHER
Peking University People's Hospital
OTHER
Zhejiang University
OTHER
Fudan University
OTHER
Sun Yat-sen University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
China-Japan Friendship Hospital
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Taihe Hospital
OTHER
Zhejiang Provincial People's Hospital
OTHER
Shanghai Zhongshan Hospital
OTHER
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weidong Mi
Director (Cheif expert of National key research and development program of China 2018YFC2001900)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mi Weidong, PhD
Role: STUDY_CHAIR
Chinese PLA hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLAGH-Frailty-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.